Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. AAPL
7. SPY
8. APLD
9. ORCL
10. USO

Go back to Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share

Capricor Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

March 15, 2017 4:10 PM EDT

LOS ANGELES, March 15, 2017 /PRNewswire/ -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company developing first-in-class biological therapies for cardiac and other medical conditions, today provided a corporate update and announced financial results for the fourth quarter and full year ended December 31, 2016.

"2016 was an eventful year for Capricor, marked by meaningful advances in our clinical development programs as well as notable corporate achievements," said Linda Marbán, Ph.D., president and chief executive officer.... More